Evidence map›Paper›PMID 34020890›Full record

Trial reportClinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology2021

Myopathic changes in patients with long-term fatigue after COVID-19.

J Agergaard, S Leth, T H Pedersen, T Harbo, J U Blicher, P Karlsson, L Østergaard, H Andersen, H Tankisi

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Advance in the mechanism and clinical research of myalgia in long COVID.American journal of clinical and experimental immunology · 2024
    Review
  19. Review
  20. Effect of Vitamin D in Long COVID Patients.International journal of environmental research and public health · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

J AgergaardDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
S LethDepartment of Medicine, Regional Hospital Unit West, Jutland, Denmark.
T H PedersenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
T HarboDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
J U BlicherDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark; Centre of Functionally Integrated Neuroscience, Aarhus University, Aarhus, Denmark.
P KarlssonDanish Pain Research Center, Aarhus University, Denmark.
L ØstergaardDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
H AndersenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
H TankisiDepartment of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: hatitank@rm.dk.
Aarhus University Hospital · DKAarhus University · DKRegional Hospital West Jutland · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the peripheral nerve and muscle function electrophysiologically in patients with persistent neuromuscular symptoms following Coronavirus disease 2019 (COVID-19).

methodsTwenty consecutive patients from a Long-term COVID-19 Clinic referred to electrophysiological examination with the suspicion of mono- or polyneuropathy were included. Examinations were performed from 77 to 255 (median: 216) days after acute COVID-19. None of the patients had received treatment at the intensive care unit. Of these, 10 patients were not even hospitalized. Conventional nerve conduction studies (NCS) and quantitative electromyography (qEMG) findings from three muscles were compared with 20 age- and sex-matched healthy controls.

resultsqEMG showed myopathic changes in one or more muscles in 11 patients (55%). Motor unit potential duration was shorter in patients compared to healthy controls in biceps brachii (10.02 ± 0.28 vs 11.75 ± 0.21), vastus medialis (10.86 ± 0.37 vs 12.52 ± 0.19) and anterior tibial (11.76 ± 0.31 vs 13.26 ± 0.21) muscles. All patients with myopathic qEMG reported about physical fatigue and 8 patients about myalgia while 3 patients without myopathic changes complained about physical fatigue.

conclusionsLong-term COVID-19 does not cause large fibre neuropathy, but myopathic changes are seen. SIGNIFICANCE: Myopathy may be an important cause of physical fatigue in long-term COVID-19 even in non-hospitalized patients.

Indexed as

AdultAgedCOVID-19ElectromyographyFatigueFemaleHumansMaleMiddle AgedMuscular DiseasesNeural ConductionRegistriesTime FactorsLong-term COVID-19 illnessMyopathyPhysical fatiguePolyneuropathyQuantitative electromyographySARS-COV-2

Identifiers

PMID34020890
PMCPMC8102077
OpenAlexW3162794570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.